Sales Ended

Malaria Drug Development & Resistance

Sales Have Ended

Registrations are closed
We are delighted you will join us on April 25th! Once you receive your registration confirmation via email, EventBrite will add you to our guest list. It is not necessary to print and bring the generated ticket.

Event Information

Share this event

Date and Time

Location

Location

Johns Hopkins Bloomberg School of Public Health

615 North Wolfe Street

Baltimore, MD 21205

View Map

Sales Have Ended

Registrations are closed
We are delighted you will join us on April 25th! Once you receive your registration confirmation via email, EventBrite will add you to our guest list. It is not necessary to print and bring the generated ticket.
Event description

Description

To be added to the waitlist, click Register.
The Johns Hopkins Malaria Research Institute is sponsoring a special malaria drug meeting to be held in conjunction with World Malaria Day, 25 April 2018 at the Bloomberg School of Public Health. The symposium will begin at 8:30 a.m. and end at 5:30 p.m., reception to follow.

The confirmed speakers are listed below:

Kelly Chibale, PhD - “PfPI4K inhibitor MMV048”
Department of Chemistry and IDM
University of Cape Town, South Africa

Tawanda Gumbo, MD - "Pharmacokinetics and Pharmacodynamics of Intracellular Pathogens in Drug Development"
Center for Infectious Diseases Research and Experimental Therapeutics
Baylor Institute of Immunology Research

Kip Guy, PhD - “SJ733 from Discovery to Clinic”
College of Pharmacy
University of Kentucky

Dennis Kyle, PhD -Mitochondrial Heteroplasmy and Atovaquone Resistance in Plasmodium falciparum
Department of Infectious Diseases
College of Veterinary Medicine
The University of Georgia

Geoff McFadden, PhD - Can We Build a Genetic Trap for Drug Resistant Malaria?
School of BioSciences
University of Melbourne, Australia

Steve Meshnick, MD, PhD - “Artemisinin – How It Works and How It Doesn’t Work
Department of Epidemiology
University of North Carolina

Margaret Phillips, PhD - Targeting Dihydroorotate Dehydrogenase for the Treatment of Malaria
Department of Biochemistry
University of Texas Southwestern Medical Center

Leo Slater, PhD - “A Brief History of Antimalaria Drug Development: Early Models and Medicine
National Science Foundation
Washington, DC

Jianping Song, MD/PhD - Mass Drug Administration on Comoros Island
Guangzhou University of Chinese Medicine
People’s Republic of China

Giovanni Traverso, MD, PhD - “Novel GI Delivery Systems in a Few Movements
Brigham and Women's Hospital
Harvard Medical School
Department of Medicine

Akhil Vaidya, PhD - "Targeting Na+ and Lipid Homeostasis in Parasites by Antimalarials"
Center for Molecular Parasitology
Drexel University

Thomas E. Wellems, MD, PhD - “Genetics of Artemisinin Delayed Clearance Phenotype”
Laboratory of Malaria and Vector Research (LMVR)
National Institute of Allergy and Infectious Diseases

Timothy Wells, FMedSci, PhD - Discovering and Delivering New Medicines to Control and Eradicate Malaria
Medicines for Malaria Venture
Geneva, Switzerland

Left image: Portrait of Eli Kennerly Marshall, Jr. who helped develope chloroquine to treat malaria. Photo credit: Chesney Medical Archives, Johns Hopkins Medical Institutions
Right image: Malaria drug administration to infant. Photo credit: Gary Knight

Date and Time

Location

Johns Hopkins Bloomberg School of Public Health

615 North Wolfe Street

Baltimore, MD 21205

View Map

Save This Event

Event Saved